Alan M. Sebulsky's most recent trade in Parabilis Medicines Inc. was a trade of 8,435 Common Stock done at an average price of $27.7 . Disclosure was reported to the exchange on June 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Parabilis Medicines Inc | Alan M. Sebulsky | Director | Purchase of securities on an exchange or from another person at price $ 27.67 per share. | 12 Jun 2026 | 8,435 | 20,935 | - | 27.7 | 233,393 | Common Stock |
| Parabilis Medicines Inc | Alan M. Sebulsky | Director | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 12 Jun 2026 | 5,000 | 25,935 | - | 26.0 | 129,989 | Common Stock |
| Parabilis Medicines Inc | Alan M. Sebulsky | Director | Purchase of securities on an exchange or from another person at price $ 27.10 per share. | 12 Jun 2026 | 4,065 | 30,000 | - | 27.1 | 110,146 | Common Stock |
| Parabilis Medicines Inc | Alan M. Sebulsky | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 11 Jun 2026 | 12,500 | 12,500 | - | 20 | 250,000 | Common Stock |
| Parabilis Medicines Inc | Alan M. Sebulsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 39,792 | 39,792 | - | - | Stock Option (Right to Buy) |